Tigermed

Tigermed

制药业

Hangzhou,Zhejiang 49,784 位关注者

Excellence. In every trial. For every patient.

关于我们

Tigermed (Stock code: 300347.SZ/3347.HK) is a leading provider of innovative clinical research solutions across the full life cycle of biopharmaceutical and medical device products globally. With a broad portfolio of services and a promise of quality, from clinical development to commercialization, we are committed to moving our customers and patients through their development journey efficiently and cost-effectively. Tigermed currently represents a worldwide network of more than 100 subsidiaries and 180 service locations, with over 10,000 employees across 50 countries in Asia Pacific, Europe, North & South America and Africa. We are devoted to building an integrated platform that enables boundless possibilities for healthcare industry, embracing challenges to fulfill our commitment to serve unmet patients’ needs, and eventually saving lives.

所属行业
制药业
规模
5,001-10,000 人
总部
Hangzhou,Zhejiang
类型
上市公司
创立
2004
领域
BE study Generic Drugs Quality Consistency Evaluation、Preclinical/CMC/Bioanalytical、Clinical related services、Regulatory Affairs、Clinical trial---Phase I to IV & NIS和MART&Oversea clinical service

地点

  • 主要

    No.19 Jugong Road, Binjiang District

    F18, Building A – Shengda Science Park

    CN,Zhejiang,Hangzhou,310053

    获取路线
  • Changning District, Shanghai,P.R.China

    Fl.16,999 West Zhongshan Road,

    CN,Shanghai,Shanghai,200051

    获取路线
  • No.20 Chaoyangmen Outer Street,Chaoyang District, Beijing,P.R.China

    Room 808,Union Mansion

    CN,Beijing,Beijing,100020

    获取路线

Tigermed员工

动态

  • 查看Tigermed的公司主页,图片

    49,784 位关注者

    During the #ESMO 2024 conference, Tigermed experts from Europe, Asia-Pacific, the Americas, and other regions gathered in Barcelona. They showcased Tigermed's extensive expertise in #antitumor drug clinical research to an international audience at booth #434. Tigermed also hosted an Exclusive Reception entitled "Leading the Next Wave in Oncology Innovation," attracting a distinguished assembly of global #oncology experts and leaders from pioneering enterprises. We are deeply grateful for everyone’s passion to interact with Tigermed at #ESMO 2024, and it is all of you that empowers what we do possible.

    • 该图片无替代文字
  • 查看Tigermed的公司主页,图片

    49,784 位关注者

    We are thrilled to be invited and to be part of the Healthcare Collaboration events in Southeast Asia, organized by GL Capital Group, which provided an outstanding opportunity to discuss with local partners and stakeholders on how our global platform to enable healthcare innovation in the region. Mr. Hao Wu, Co-President of Tigermed, Mr. Hua Shao, Vice President and Head of Tigermed Southeast Asia & Latin America, and other colleagues from Indonesia and Singapore attended the events and showcased what Tigermed can support to drive innovation and improve sustainable healthcare in Southeast Asia. #southeastasia #tigermed #singapore #indonesia #clinicaltrials

    • 该图片无替代文字
    • 该图片无替代文字
    • 该图片无替代文字
    • 该图片无替代文字
  • 查看Tigermed的公司主页,图片

    49,784 位关注者

    We are proud to announce the collaboration and MOU (Memorandum of Understanding) signing ceremony with Purpose Africa last Friday in Hangzhou, China, which represents a new direction in China-Africa collaboration in clinical research and digital platform. Its implementation will open new pathways for Africa countries to access clinical resources and higher-quality pharmaceuticals products from China, and will be a step forward in our joint efforts to advance global clinical trials. #clinicaltrials #china #africa #clinicalresearch

    • 该图片无替代文字
    • 该图片无替代文字
    • 该图片无替代文字
    • 该图片无替代文字
    • 该图片无替代文字
      +1
  • 查看Tigermed的公司主页,图片

    49,784 位关注者

    New page exploration in action with #Tigermed We have flexible service capabilities with a global network of trusted medical and clinical translators, covering over 80 #languages across locations where clinical research take place. We established a strict translation workflow and quality assurance system to provide #timely and #accurate translation and interpretation services. It covers all #medical fields including drugs, medical devices, regulations, biological products, animal health, vaccines, health nutrition, cosmetics, training and other products or materials. Learn more about Tigermed's capabilities and connect for a conversation at https://lnkd.in/g9Q5Kd7W

    • 该图片无替代文字
  • 查看Tigermed的公司主页,图片

    49,784 位关注者

    HANGZHOU, China, Aug. 28, 2024 -- Hangzhou Tigermed Consulting Co., Ltd. (Stock code: 300347.SZ / 3347.HK), a leading provider of clinical research solutions across full lifecycle of global biopharmaceutical and medical device products, announced its interim results for the first half of 2024, ended June 30, 2024 (the "Reporting Period"). Tigermed has maintained its leading position in China's clinical service market, holding a 12.8% market share in 2023. Notably, it was the only Chinese CRO to rank among the global top 10 that year, with a global market share of 1.4%. As of June 30, 2024, Tigermed had a total of 9,348 employees across 37 countries. During the reporting period, Tigermed accumulated experience in handling over 133 multi-region clinical trials (MRCTs) and is currently executing 55 MRCT projects. Read the full press release at https://lnkd.in/gRNhcx56 #2024 #InterimResults #CRO #market

    Tigermed Reports 2024 Interim Results

    Tigermed Reports 2024 Interim Results

    prnewswire.com

  • 查看Tigermed的公司主页,图片

    49,784 位关注者

    You’re Invited to an Exclusive Tigermed Reception at #ESMO2024! Join us for an evening of #innovation and #networking at the W Barcelona on Saturday, September 14th, 2024. At the Tigermed reception, you’ll have the opportunity to: ·    Discover the latest global oncology trends ·    Engage in thought-provoking discussions with industry leaders ·    Connect with top professionals in the oncology field 🗓️ Reception Agenda: 18:00 - 18:30 Check-in 18:30 - 18:35 Opening Remarks, Hao Wu, Co-President, Tigermed 18:35 - 18:50 Keynote "Navigating the Future of Oncology: Capitalizing on Cutting-Edge Advancements" , Britney Winterberger, Senior Clinical Project Director, Tigermed  18:50 - 19:05 Keynote "Licensing Trends in China: Driving Pharma Innovation and Regulatory Evolution" , Xiaohua Zhang, Senior Regulatory Affairs Director, Tigermed  19:05 - 21:00 Reception | Networking Secure your spot now: https://lnkd.in/gtgrhR6R  We look forward to seeing you there!

    • 该图片无替代文字
  • 查看Tigermed的公司主页,图片

    49,784 位关注者

    Join Us for Tigermed’s Exclusive Reception at ESMO 2024! We are delighted to invite you to an exclusive reception hosted by Tigermed at the stunning W Barcelona during the ESMO Congress 2024. ·    Date: Saturday, September 14th, 2024 ·    Time: 18:00 - 21:00 CEST ·    Venue: W Barcelona, 1 Plaça de la Rosa dels Vents, E Floor, Breeze Room, 08039 Barcelona, Spain This exceptional event offers a perfect blend of insightful presentations and valuable networking opportunities. Experience the latest global oncology trends, engage in thought-provoking discussions with industry leaders, and connect with top professionals in the field. Don't miss out on this memorable evening! Secure your spot by registering Here. We look forward to seeing you there! #Reception #ESMO #Oncology #Innovation

    • 该图片无替代文字

相似主页

融资

Tigermed 共 2 轮

上一轮

未知

US$2,000,000.00

Crunchbase 上查看更多信息